Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Parinaud Oculoglandular Syndrome: Causes and Treatment
Parinaud oculoglandular syndrome is a relatively rare yet intriguing medical condition that intertwines ocular and glandular manifestations. Characterized by its distinct combination of eye-related symptoms and glandular involvement, this syndrome presents a unique challenge for both patients and medical professionals.…
Herpes Zoster Ophthalmicus | OBN
Herpes Zoster Ophthalmicus (HZO), commonly known as shingles, is a viral disease characterized by a unilateral painful skin rash in one or more dermatome distributions of the fifth cranial nerve (trigeminal nerve), shared by the eye and ocular adnexa. Herpes…
VSY Biotechnology AcrivaUD Trinova Pro C Pupil Adaptive® I OBN
VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, is readying to share the first clinical experiences of AcrivaUD Trinova Pro C Pupil Adaptive®, the first and only trifocal IOL that combines patented enhanced Sinusoidal Vision Technology…
What Is Diffuse Lamellar Keratitis and How to Manage It
What is Diffuse Lamellar Keratitis (DLK)? Diffuse Lamellar Keratitis, commonly referred to as DLK, is an inflammatory condition that can occur following LASIK (Laser-Assisted In Situ Keratomileusis) eye surgery. DLK is characterized by inflammation in the corneal flap, which is…
Pros and Cons of Light Adjustable Lens (LAL)
Light Adjustable Lens (LAL) technology is a groundbreaking advancement in the field of ophthalmology, offering a novel approach to vision correction and the treatment of cataracts. Unlike traditional intraocular lenses that are permanently fixed in their refractive power, LALs can…
Ocuphire and Viatris Unveil FDA Approval for Ryzumvi
Ocuphire Pharma and Viatris announced that the FDA has granted approval for Ryzumvi (phentolamine ophthalmic solution) 0.75%. This approval specifically authorizes its use in the treatment of pharmacologically-induced mydriasis, produced by adrenergic agonists (such as phenylephrine) or parasympatholytic agents (like…
Thea Pharma Introduces Glaucoma Drug Iyuzeh in the U.S.
Thea Pharma announced the launch and availability of Iyuzeh (latanoprost ophthalmic solution) 0.005% in the United States market. Iyuzeh, having obtained FDA approval in December 2022, stands as the first preservative-free latanoprost product for individuals in the US diagnosed with…
What Is the Cost of Bimatoprost Eye Drops?
Bimatoprost is a medicine that helps with high pressure in the eye (OCT) and open-angle glaucoma. When too much fluid builds up in your eyes the pressure in the eye increases. Bimatoprost drops help to drain the excess fluid, and…
What Is Amniotic Membrane Transplantation?
What Is Amniotic Membrane Transplantation? Amniotic membrane transplantation (AMT) is a surgical procedure that involves using the amniotic membrane, which is the innermost layer of the placenta, to treat a variety of ocular, dermatological, and other medical conditions. The amniotic membrane…
What Is Transscleral Cyclophotocoagulation? | OBN
What Is Transscleral Cyclophotocoagulation? Transscleral Cyclophotocoagulation (TCP) is a minimally invasive surgical procedure used to treat glaucoma, a group of eye diseases that cause damage to the optic nerve resulting in vision loss. It is an alternative to traditional glaucoma…